Patricia Imbach-weese

Title: Innovations of Patricia Imbach-Weese

Introduction

Patricia Imbach-Weese is a notable inventor based in Bielefeld, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific protein interactions.

Latest Patents

Patricia holds two patents that showcase her innovative work. The first patent is titled "Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of Bruton's tyrosine kinase inhibitors." This invention relates to compounds that are crucial in the synthesis of inhibitors that can potentially treat various diseases. The second patent is "Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors." This patent provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, which is significant in the field of cancer research.

Career Highlights

Patricia is currently employed at Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on innovative solutions in drug development and therapeutic interventions.

Collaborations

Throughout her career, Patricia has collaborated with talented individuals such as Vincent Bordas and Cara Brocklehurst. These collaborations have enhanced her research and contributed to the success of her inventions.

Conclusion

Patricia Imbach-Weese's contributions to the field of pharmaceutical chemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments.